Metformin and risk of age-related macular degeneration in individuals with type 2 diabetes: a retrospective cohort study

Conclusion
We found no evidence that metformin was associated with risk of AMD in primary care patients requiring treatment for type 2 diabetes.

Source: British Journal of Ophthalmology - June 22, 2023 Category: Opthalmology Authors: Gokhale, K. M., Adderley, N. J., Subramanian, A., Lee, W. H., Han, D., Coker, J., Braithwaite, T., Denniston, A. K., Keane, P. A., Nirantharakumar, K. Tags: Original articles - Clinical science Source Type: research